Clinical Trials Browser

Phase 1/2 × Withdrawn × Tacrolimus × Clear all

NCT00995059 2023-01-05

Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma

Phase 1/2 Withdrawn

Multiple Myeloma

NCT04961801 2022-03-08

Acalabrutinib for GVHD Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation in Lymphomas and Leukemia

Phase 1/2 Withdrawn

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma